Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Aristotle testing and future Alberta cancer test pilot
View:
Post by LithLover on May 05, 2023 9:03pm

Aristotle testing and future Alberta cancer test pilot

Danielle Smith is premier of Alberta.  There is a presentation on the pilot program Mike is talking about:


https://www.youtube.com/watch?v=W7Ocamdf-rw

https://podcasts.apple.com/gb/podcast/cancer-and-cardiovascular-screening-pilot-mike/id1485886197?i=1000569031234
StageZero Life Sciences Ltd. (TSX: SZLS)
Private blood testing is back in Canada! You deserve better health care, and we want to be part of the solution.

https://lnkd.in/ebZeFbCu
 
Many important lessons were learned during the Ichor days, both
from a business management perspective, as well as an understanding of the market. When Ichor didn't make it, Almin Kassamali believed in the Ichor model, and he believed in me. I am very proud to be part of this new organization and look forward to helping drive change in Health Care for the benefit of all.
 
Health Today offers private blood tests from Mayo Clinic
Laboratories in Rochester, as well as early cancer detection tests from StageZero Life Sciences Ltd. (TSX: SZLS). We also plan to offer an alternate access point for public health lab collections by Q3 of this year. Health Today plans to work with the insurance industry to help underwrite new, low premium products. We plan to work with employers to nurture healthier work forces and stay ahead of long absences and leaves. And I believe most importantly we also
plan on following through with our cancer and cardiovascular screening program, and intend on holding Danielle Smith true to her word to execute this pilot program and do things differently. Early detection of cancer and cardiovascular disease has a MASSIVE
impact on mortality rates, quality of life, and health care costs. We have the tools, lets put them to use.
 
I am very excited about this next chapter and the potential it has
for changing the health care delivery model. Thank you for your continued support, together we can drive change.

Comment by IainCaimbeul on May 08, 2023 3:22pm
This is really old "news". Looks like Mike K has landed on his feet after the Ichor covid testing bonanza. A quick look at the revenue pattern between Stagezero and Ichor from just before covid (sic) panicdema until now are very similiar. Ichor kept it's site active for 6 months knowing full well it was going Tango Uniform - sleaze. HealthToday - yeah.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities